Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors. 1991

M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
Tohoku College of Pharmacy, Sendai, Japan.

Androst-4-en-17-one derivatives [19-acetoxide 4, 16-bromides 14 and 15, 19,19-difluoride 18, and (19R,S)-19-acetylenic alcohol 25] and androst-4-en-17 beta-ol derivatives 3, 5, 10, 12, and 19 were synthesized and tested for their ability to inhibit aromatase in human placental microsomes. All the 17-oxo steroids, except compound 25 and 17,19-diol 3 of this series, were effective competitive inhibitors with apparent Ki's ranging from 170 to 455 nM. 19,19-Difluoro steroid 18 and 19-acetylenic alcohol 25, a weak competitive inhibitor (Ki = 7.75 microM), caused a time-dependent, pseudo-first-order inactivation of aromatase activity with kinact's of 0.0213 and 0.1053 min-1 for compounds 18 and 25, respectively. NADPH and oxygen were required for the time-dependent inactivation, and the substrate, androst-4-ene-3,17-dione, prevented it, but a nucleophile, L-cysteine, did not in each case. The results strongly suggest that aromatase would attack the 19-carbon of steroids 18 and 25.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000736 Androstenes Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.
D000737 Androstenols Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system. Hydroxyandrostenes
D001141 Aromatase An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system. CYP19,Cytochrome P-450 CYP19,Cytochrome P-450(AROM),Androstenedione Aromatase,CYP 19,CYP19 Protein,Cytochrome P450 19,Estrogen Synthase,Estrogen Synthetase,P450AROM,Aromatase, Androstenedione,Cytochrome P 450 CYP19,Protein, CYP19

Related Publications

M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
December 2008, Steroids,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
May 1996, Journal of medicinal chemistry,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
July 1995, Journal of medicinal chemistry,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
October 1998, The Journal of steroid biochemistry and molecular biology,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
January 1990, Journal of medicinal chemistry,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
October 1994, Steroids,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
August 2003, Steroids,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
August 1968, Journal of chromatography,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
August 1995, The Journal of steroid biochemistry and molecular biology,
M Numazawa, and A Mutsumi, and K Hoshi, and M Oshibe, and E Ishikawa, and H Kigawa
July 2013, Steroids,
Copied contents to your clipboard!